Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-01-03 @ 3:28 AM
Study NCT ID:
NCT02475460
Status:
COMPLETED
Last Update Posted:
2022-06-24
First Post:
2015-06-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HeartMate 3™ LIS Study
Sponsor:
Abbott Medical Devices
Organization:
Study Overview
Official Title:
Thoratec Corporation HeartMate 3™ Less Invasive Surgery (LIS) Study
Status:
COMPLETED
Status Verified Date:
2022-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HM 3 LIS
Brief Summary:
The purpose of this study is to evaluate a less invasive implantation technique of the HeartMate 3 Left Ventricular Assist System (HM 3 LVAS) in 10 patients.
Detailed Description:
This study will evaluate the less invasive implantation technique of the HM 3 LVAS.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: